BARRICAID ACD (ANNULAR CLOSURE DEVICE)
Device
Intrinsic Therapeutics
Total Payments
$1.1M
Transactions
2,801
Doctors
778
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $454,475 | 1,504 | 280 |
| 2023 | $347,500 | 825 | 383 |
| 2022 | $331,038 | 472 | 269 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $543,331 | 447 | 48.0% |
| Consulting Fee | $300,332 | 303 | 26.5% |
| Food and Beverage | $145,525 | 1,852 | 12.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $92,938 | 100 | 8.2% |
| Travel and Lodging | $45,637 | 94 | 4.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,250 | 5 | 0.5% |
Payments by Type
General
$589,682
2,354 transactions
Research
$543,331
447 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Post-Marketing Clinical Follow-up of an Annular Closure System (Barricaid) | Intrinsic Therapeutics | $183,399 | 12 |
| Prospective Evaluation Of Lumbar Discectomy With Additional Implantation Of An Annular Closure Device In Patients With Large Postsurgical Annular Defects For Prevention Of Lumbar Disc Reherniation | Intrinsic Therapeutics | $178,557 | 2 |
| FREEDOM Lumbar Discectomy Registry | Intrinsic Therapeutics | $153,000 | 51 |
| Prospective Evaluation of Lumbar Discectomy with Additional Implantation of an Annular Closure Device in Patients with Large Postsurgical Annular Defects for Prevention of Lumbar Disc Reherniation | Intrinsic Therapeutics | $28,375 | 1 |
Top Doctors Receiving Payments for BARRICAID ACD (ANNULAR CLOSURE DEVICE)
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Shereveport, LA | $195,457 | 29 |
| , RPAC | Surgical | Williamsville, NY | $78,453 | 14 |
| , M.D | Neurological Surgery | Evanston, IL | $77,290 | 55 |
| , MD | Neurological Surgery | Gainesville, GA | $65,570 | 94 |
| , MD | Neurological Surgery | Union, NJ | $56,782 | 76 |
| , MD | Orthopaedic Surgery of the Spine | Herrin, IL | $46,911 | 59 |
| , MD | Orthopaedic Surgery | Shreveport, LA | $44,548 | 12 |
| , M.D | Orthopaedic Surgery | Morganton, NC | $41,551 | 58 |
| , PA-C | Medical | Virginia Beach, VA | $27,973 | 56 |
| , MD | Orthopaedic Surgery of the Spine | Woburn, MA | $26,077 | 20 |
| , PAC | Physician Assistant | Herrin, IL | $17,283 | 38 |
| , MD | Orthopaedic Surgery | Stanford, CA | $15,932 | 26 |
| , M.D | Orthopaedic Trauma | Dallas, TX | $15,513 | 27 |
| , M.D | Neurological Surgery | Norfolk, VA | $13,786 | 10 |
| , MD | Neurological Surgery | Albuquerque, NM | $12,488 | 18 |
| , M.D | Neurological Surgery | Tucson, AZ | $12,169 | 20 |
| , M.D | Orthopaedic Surgery of the Spine | Carmel, IN | $11,550 | 5 |
| , MD | Orthopaedic Surgery | Hamden, CT | $10,000 | 5 |
| , PA-C | Surgical | Tigard, OR | $8,092 | 5 |
| , MD | Orthopaedic Surgery of the Spine | New York, NY | $7,033 | 9 |
| , M.D | Neurological Surgery | Chestnut Hill, MA | $7,013 | 4 |
| , M.D., PH.D | Diagnostic Radiology | Fairfax, VA | $7,013 | 4 |
| , M.D | Orthopaedic Surgery of the Spine | San Diego, CA | $6,038 | 14 |
| , MD | Neurological Surgery | Knoxville, TN | $6,000 | 5 |
| , M.D | Neurological Surgery | Idaho Falls, ID | $5,970 | 8 |
Ad
Manufacturing Companies
- Intrinsic Therapeutics $1.1M
Product Information
- Type Device
- Total Payments $1.1M
- Total Doctors 778
- Transactions 2,801
About BARRICAID ACD (ANNULAR CLOSURE DEVICE)
BARRICAID ACD (ANNULAR CLOSURE DEVICE) is a device associated with $1.1M in payments to 778 healthcare providers, recorded across 2,801 transactions in the CMS Open Payments database. The primary manufacturer is Intrinsic Therapeutics.
Payment data is available from 2022 to 2024. In 2024, $454,475 was paid across 1,504 transactions to 280 doctors.
The most common payment nature for BARRICAID ACD (ANNULAR CLOSURE DEVICE) is "Unspecified" ($543,331, 48.0% of total).
BARRICAID ACD (ANNULAR CLOSURE DEVICE) is associated with 4 research studies, including "Post-Marketing Clinical Follow-up of an Annular Closure System (Barricaid)" ($183,399).